Healthcare

Impact Expansion has raised €150m for Impact Expansion Fund I and announced the fund’s first investment in Belgium into sustainable energy solutions provider BeliVert.

A report from Better Society Capital shows how the use of outcomes contracts is spreading in the UK, and quantifies their benefits in tackling social and health problems.

The Dutch healthtech venture builder will use the funds to bring more potentially groundbreaking healthcare innovations to market.

Kelix Bio, an emerging market biopharmaceutical platform, has been wholly acquired by Abu Dhabi investor Mubadala Investment Company.

NLC Health Ventures has raised €58m since 2023, including €14m this year, to invest in bringing innovations to market that will relieve mounting pressures on healthcare systems globally, it says.

Fund IV has received backing from a range of institutional investors, DFIs and philanthropies. It will invest in rapidly scaling financial services and healthcare businesses in global growth markets in Africa and Asia.

The Belgium-based fund is investing in a dozen companies that aim to achieve systemic changes in environment, skilling & education, and health sectors.

The great majority of healthtech innovations never reach patients due to lack of early-stage funding and business expertise. NLC is changing that by building investible businesses around game-changing healthcare solutions.

Biju Mohandas, global co-head of healthcare investments at LeapFrog Investments, tell us that a “secular shift” in the attitude towards healthcare technology has taken place.

We talk to scientist Susan Greenfield, founder of Neuro-Bio, about her breakthrough discovery in the search for a cure to Alzheimer’s, and the potentially huge social impact of investments in biotech.